Willingness of pregnant and postpartum women who use marijuana and/or cannabidiol to participate with their offspring in long-term cohort studies: an exploratory study
View abstract on PubMed
Summary
This summary is machine-generated.Pregnant and postpartum women using marijuana or cannabidiol are willing to join long-term studies if researchers build trust and ensure anonymity. Clear communication about data use and appropriate incentives are crucial for participation in maternal-child health research.
Area Of Science
- Reproductive Health
- Perinatal Research
- Cannabinoid Science
Background
- Marijuana and cannabinoid use is rising in reproductive-age women.
- Long-term effects of prenatal exposure on mother-infant dyads require further study.
- Recruiting and retaining substance-exposed women in longitudinal research presents challenges.
Purpose Of The Study
- To explore the willingness of pregnant and postpartum women using marijuana and/or cannabidiol to participate in long-term cohort studies with their offspring.
Main Methods
- Conducted 4 focus groups and 1 individual interview with 17 pregnant or postpartum women.
- Utilized an IRB-approved interview guide, audiotaped and transcribed all sessions.
- Employed deductive content analysis with consensus coding using Atlas.ti software.
Main Results
- Participants are willing to engage in long-term research if a trusting relationship with staff is established and anonymity is assured.
- Concerns about protection from negative consequences necessitate clear communication regarding data collection, access, and usage.
- Incentives are considered important, with participants offering diverse suggestions on type and frequency.
Conclusions
- Study protocols for marijuana/cannabinoid-exposed pregnant women must carefully consider participant concerns and needs.
- Building trust, ensuring anonymity, and transparent data handling are key to successful recruitment and retention.
- Tailored incentives can enhance participation in perinatal substance-use research.
Related Concept Videos
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

